Menu

Specialized Solutions Discovery
Booster

Innovation thrives on momentum. Benuvia accelerates your journey from concept to molecule with tailored strategies, advanced technologies, and expert guidance.

Turning Your Molecules
Into Milestones Met

Accelerate your journey from concept to breakthrough.

Our streamlined workflows and expert teams eliminate barriers, enabling you to develop and refine your product faster than ever. With Discovery Booster, you don’t just move quickly—you move with purpose, precision, and the confidence to reach your next milestone.

Accelerating API & Drug Substance Development

The Discovery Booster program leverages Benuvia’s advanced capabilities to accelerate drug development with precision, efficiency, and regulatory excellence. Features include:

  • Synthetic Development for Complex APIs
  • Advanced Purification Techniques
  • Tailored Analytical Development
  • Unified R&D and Manufacturing Support

Synthetic Development for Complex APIs

Benuvia specializes in designing efficient synthetic pathways for cannabinoids, psychedelics, and non-
controlled substance small molecule APIs. By using ICH-compliant processes, we deliver APIs with exceptional purity and reproducibility, ensuring your drug candidates meet stringent global regulatory requirements.

Advanced Purification Techniques

Our advanced purification methods, including distillation and crystallization, enhance yield while reducing impurities to trace levels. This ensures APIs meet or exceed analytical standards, supporting early-stage development and setting the foundation for long-term product quality.

Tailored Analytical Development

Every molecule benefits from dedicated AD Chemists who develop and validate methods across API manufacturing and dosage forms like injectables, oral capsules, and topical creams. Our expertise ensures accurate, reproducible results that comply with global regulatory guidelines and drive project success.

Integrated R&D and Manufacturing Support

By uniting R&D and manufacturing capabilities, Benuvia minimizes delays and ensures a seamless transition from discovery to production. Our collaborative approach supports scalability and optimizes processes for consistent results in API development.

Discovery Booster was instrumental in accelerating our drug development timeline. The team’s expertise in hit-to-process optimization and tailored analytical development ensured our molecule was not only viable but optimized for further development. The seamless collaboration between their synthetic teams and our preclinical teams saved us valuable time and resources, allowing us to progress to the next stage with confidence.

Mid-Sized Biotech Specializing in Rare Diseases

QC Manager

Speak with an Expert

Aruna Earla, Ph.D.

Director API Research and Development

Dr. Aruna Earla serves as the Director of the Research and Development group at Benuvia Operations, where she has been working since 2020. She is involved in the process development of Active Pharmaceutical Ingredients (APIs). With approximately 20 years of experience in pharmaceutical research, development, and manufacturing within the CRO and CDMO sectors, Dr. Earla brings a wealth of expertise to her role. She holds an M.S. in Organic Chemistry, an M.S. in Biotechnology, and a Ph.D. in Organic Chemistry. Her extensive experience in organic synthesis covers a wide range of chemistries, including cannabinoids and psychedelics. Dr. Earla’s contributions are significant, spanning from initial route scouting to the commercial manufacturing of APIs. Before joining Benuvia, she held Research Scientist positions at Alembic, Dr. Reddy’s, Olon-Ricerca Biosciences, and Nanosyn.

Contact Me

"*" indicates required fields

Consent